Xanthogranulomatous cholecystitis mimicking gallbladder cancer on 18F-fluorodeoxyglucose positron emission tomography/computed tomography scan

Nitin Gupta; Ritu Verma; Ethel Belho; Shashi Dhawan

doi:10.4103/wjnm.WJNM_118_20

World Journal of Nuclear Medicine, Inhaltsverzeichnis

CC BY-NC-ND 4.0 · World J Nucl Med 2021; 20(01): 93-95
DOI: 10.4103/wjnm.WJNM_118_20

Case Report

Xanthogranulomatous cholecystitis mimicking gallbladder cancer on ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography scan

Nitin Gupta

Department of Nuclear Medicine and PET/CT Mahajan Imaging Centre, Sir Ganga Ram Hospital, New Delhi, India

,

Ritu Verma

Department of Nuclear Medicine and PET/CT Mahajan Imaging Centre, Sir Ganga Ram Hospital, New Delhi, India

,

Ethel Belho

Department of Nuclear Medicine and PET/CT Mahajan Imaging Centre, Sir Ganga Ram Hospital, New Delhi, India

,

Shashi Dhawan

¹Department of Pathology, Sir Ganga Ram Hospital, New Delhi, India

› Institutsangaben

Abstract

The abnormal thickening of the gallbladder (GB) wall can be caused by a malignant condition like gallbladder carcinoma or by benign lesions such as chronic cholecystitis or xanthogranulomatous cholecystitis (XGC). Mural thickening is a common finding between them as fluorodeoxyglucose (FDG) can be taken up by inflammatory cells also. Here, we present a patient with irregular thickening of the GB wall which was suspected to of GB carcinoma since FDG positron emission tomography/computed tomography scan showed increased tracer uptake in the lesion. However, after surgery the histopathological report was suggestive of XGC.

Keywords

Gallbladder cancer - positron emission tomography/computed tomography scan - xanthogranulomatous cholecystitis

Volltext

Referenzen

References
1 Zhuang PY, Zhu MJ, Wang JD, Zhou XP, Quan ZW, Shen J. Xanthogranulomatous cholecystitis: A clinicopathological study of its association with gallbladder carcinoma. J Dig Dis 2013;14:45-50.
2 Christensen AH, Ishak KG. Benign tumors and pseudotumors of the gallbladder. Report of 180 cases. Arch Pathol 1970;90:423-32.
3 McCoy JJ Jr., Vila R, Petrossian G, McCall RA, Reddy KS. Xanthogranulomatous cholecystitis. Report of two cases. J S C Med Assoc 1976;72:78-9.
4 Zhao F, Lu PX, Yan SX, Wang GF, Yuan J, Zhang SZ, et al. CT and MR features of xanthogranulomatous cholecystitis: An analysis of consecutive 49 cases. Eur J Radiol 2013;82:1391-7.
5 Bo X, Chen E, Wang J, Nan L, Xin Y, Wang C, et al. Diagnostic accuracy of imaging modalities in differentiating xanthogranulomatous cholecystitis from gallbladder cancer. Ann Transl Med 2019;7:627.
6 Ewelukwa O, Ali O, Akram S. Xanthogranulomatous cholecystitis mimicking gallbladder cancer. BMJ Case Rep 2014;2014:bcr2013200530.
7 Makino I, Yamaguchi T, Sato N, Yasui T, Kita I. Xanthogranulomatous cholecystitis mimicking gallbladder carcinoma with a false-positive result on fluorodeoxyglucose PET. World J Gastroenterol 2009;15:3691-3.
8 Han SH, Chen YL. Diagnosis and treatment of xanthogranulomatous cholecystitis: A report of 39 cases. Cell Biochem Biophys 2012;64:131-5.
9 Goshima S, Chang S, Wang JH, Kanematsu M, Bae KT, Federle MP. Xanthogranulomatous cholecystitis: Diagnostic performance of CT to differentiate from gallbladder cancer. Eur J Radiol 2010;74:e79-83.
10 Anderson CD, Rice MH, Pinson CW, Chapman WC, Chari RS, Delbeke D. Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma. J Gastrointest Surg 2004;8:90-7.
11 Sawada S, Shimada Y, Sekine S, Shibuya K, Yoshioka I, Matsui K, et al. Expression of GLUT-1 and GLUT-3 in xanthogranulomatous cholecystitis induced a positive result on (18)F-FDG PET: Report of a case. Int Surg 2013;98:372-8.